Risk reduction surgery (RRS) for tubo-ovarian cancer in an Irish gynaecological practice: an analysis of indications and outcomes
ConclusionMore than 60% of women undergoing RRS were BRCAm negative or untested. Counselling of high-risk women without defined germline mutations remains a challenge for gynaecologists because the likelihood of removing STIC lesions or occult invasive cancer is low. Removal of coincidental pathology may give added value to RRS in these women.
More News: Biomedical Science | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Endometrial Cancer | Endometriosis | Fallopian Tube Cancer | General Medicine | Genetics | Hysterectomy | Ireland Health | OBGYN | Ovarian Cancer | Ovaries | Pathology | Science | Serous Carcinoma | Teaching | Teaching Hospitals | Universities & Medical Training | Women